Skip To Main Content
Meta H.M. Diekstra on Muck Rack

Meta H.M. Diekstra

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Meta H.M.

Contact Meta H.M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Letter to the editor: Comments on ‘A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation’

|
By Stefan Sleijfer, Meta H.M. Diekstra, Ruben Malmberg
| European Journal of Cancer Verified
With great interest, we read the research article of Lala et al. [ 1 Lala M. Li T.R. de Alwis D.P. Sinha V. Mayawala K. Yamamoto N. et al. A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. ]. The authors present a robust population pharmacokinetic (PPK) model of pembrolizumab with data from 2993 patients and a thorough data interpretation.
Open in Who Shared Issue with article?
See all 1 articles